A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Nash Chevrolet from DealerRater. Want to share your experience with this ...
Around this time last year, Akero was riding high on positive phase 2b data for its candidate non-alcoholic steatohepatitis (NASH) therapy, but new data has dented optimism about the project. Results ...
Denmark's Novo Nordisk has agreed to pay $70 million to license rights to a drug developed by Ventus Therapeutics with potential in non-alcoholic steatohepatitis (NASH) and several other diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback